Protagonist Therapeutics Inc (PTGX)
Days of sales outstanding (DSO)
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Receivables turnover | — | 6.93 | 5.15 | 7.21 | 0.02 | |
| DSO | days | — | 52.65 | 70.92 | 50.65 | 23,196.06 |
December 31, 2023 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ —
= —
The days of sales outstanding (DSO) for Protagonist Therapeutics Inc have been fluctuating over the past five years. In 2019, the DSO was exceptionally high at 23,196.06 days, which indicates a significant delay in collecting accounts receivable. This may have been due to various factors such as inefficient credit and collection policies or operational issues.
The DSO improved significantly in 2020 to 50.65 days, indicating a more efficient collection process. However, it spiked again in 2021 to 70.92 days before decreasing to 52.65 days in 2022. This fluctuation suggests that Protagonist Therapeutics Inc may still be facing challenges in managing its accounts receivable effectively.
Overall, the trend in DSO shows that Protagonist Therapeutics Inc has made some progress in improving its collection efficiency, but there is still room for further optimization in managing its accounts receivable to ensure a smoother cash flow and financial stability.
Peer comparison
Dec 31, 2023